Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $5.53 billion. The enterprise value is $5.60 billion.
| Market Cap | 5.53B |
| Enterprise Value | 5.60B |
Important Dates
The next estimated earnings date is Wednesday, April 22, 2026, after market close.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | Feb 23, 2026 |
Share Statistics
Chemed has 13.77 million shares outstanding. The number of shares has decreased by -4.78% in one year.
| Current Share Class | 13.77M |
| Shares Outstanding | 13.77M |
| Shares Change (YoY) | -4.78% |
| Shares Change (QoQ) | -2.77% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 102.16% |
| Float | 13.53M |
Valuation Ratios
The trailing PE ratio is 21.91 and the forward PE ratio is 16.74. Chemed's PEG ratio is 1.45.
| PE Ratio | 21.91 |
| Forward PE | 16.74 |
| PS Ratio | 2.19 |
| Forward PS | 2.04 |
| PB Ratio | 5.63 |
| P/TBV Ratio | 25.17 |
| P/FCF Ratio | 17.00 |
| P/OCF Ratio | 14.25 |
| PEG Ratio | 1.45 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.85, with an EV/FCF ratio of 17.21.
| EV / Earnings | 21.12 |
| EV / Sales | 2.21 |
| EV / EBITDA | 13.85 |
| EV / EBIT | 16.29 |
| EV / FCF | 17.21 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.05 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.44 |
| Interest Coverage | 196.49 |
Financial Efficiency
Return on equity (ROE) is 25.28% and return on invested capital (ROIC) is 23.99%.
| Return on Equity (ROE) | 25.28% |
| Return on Assets (ROA) | 13.40% |
| Return on Invested Capital (ROIC) | 23.99% |
| Return on Capital Employed (ROCE) | 27.49% |
| Weighted Average Cost of Capital (WACC) | 6.62% |
| Revenue Per Employee | $160,014 |
| Profits Per Employee | $16,776 |
| Employee Count | 15,811 |
| Asset Turnover | 1.58 |
| Inventory Turnover | 216.93 |
Taxes
In the past 12 months, Chemed has paid $90.54 million in taxes.
| Income Tax | 90.54M |
| Effective Tax Rate | 25.45% |
Stock Price Statistics
The stock price has decreased by -31.80% in the last 52 weeks. The beta is 0.46, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -31.80% |
| 50-Day Moving Average | 439.93 |
| 200-Day Moving Average | 455.90 |
| Relative Strength Index (RSI) | 35.82 |
| Average Volume (20 Days) | 271,726 |
Short Selling Information
The latest short interest is 459,863, so 3.34% of the outstanding shares have been sold short.
| Short Interest | 459,863 |
| Short Previous Month | 647,317 |
| Short % of Shares Out | 3.34% |
| Short % of Float | 3.40% |
| Short Ratio (days to cover) | 2.12 |
Income Statement
In the last 12 months, Chemed had revenue of $2.53 billion and earned $265.24 million in profits. Earnings per share was $18.34.
| Revenue | 2.53B |
| Gross Profit | 823.18M |
| Operating Income | 343.86M |
| Pretax Income | 355.78M |
| Net Income | 265.24M |
| EBITDA | 404.40M |
| EBIT | 343.86M |
| Earnings Per Share (EPS) | $18.34 |
Balance Sheet
The company has $74.52 million in cash and $143.76 million in debt, with a net cash position of -$69.24 million or -$5.03 per share.
| Cash & Cash Equivalents | 74.52M |
| Total Debt | 143.76M |
| Net Cash | -69.24M |
| Net Cash Per Share | -$5.03 |
| Equity (Book Value) | 979.41M |
| Book Value Per Share | 71.43 |
| Working Capital | 15.49M |
Cash Flow
In the last 12 months, operating cash flow was $388.27 million and capital expenditures -$62.80 million, giving a free cash flow of $325.48 million.
| Operating Cash Flow | 388.27M |
| Capital Expenditures | -62.80M |
| Free Cash Flow | 325.48M |
| FCF Per Share | $23.65 |
Margins
Gross margin is 32.54%, with operating and profit margins of 13.59% and 10.48%.
| Gross Margin | 32.54% |
| Operating Margin | 13.59% |
| Pretax Margin | 14.06% |
| Profit Margin | 10.48% |
| EBITDA Margin | 15.98% |
| EBIT Margin | 13.59% |
| FCF Margin | 12.86% |
Dividends & Yields
This stock pays an annual dividend of $2.40, which amounts to a dividend yield of 0.60%.
| Dividend Per Share | $2.40 |
| Dividend Yield | 0.60% |
| Dividend Growth (YoY) | 21.05% |
| Years of Dividend Growth | 17 |
| Payout Ratio | 12.54% |
| Buyback Yield | 4.78% |
| Shareholder Yield | 5.38% |
| Earnings Yield | 4.79% |
| FCF Yield | 5.88% |
Analyst Forecast
The average price target for Chemed is $498.00, which is 23.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $498.00 |
| Price Target Difference | 23.92% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 12.98 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.98 |
| Piotroski F-Score | 5 |